Subscribe To
Structure therapeutics starts u.s. ipo plan
Structure Therapeutics has filed to raise $119 million in a U.S. IPO, although the final figure may differ. The firm is developing ...
January 17, 2023, 1:09 pm
Medivir to present at the redeye fight cancer day
STOCKHOLM , Jan. 16, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative ...
January 16, 2023, 3:41 am
: drug companies plan to raise prices on vital medicines to fund r&d, but they already spend more on shareholder returns than research
Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But...
January 14, 2023, 6:40 pm
Entrepreneur maricela cortez launches bella glam academy for aspiring beauty professionals
LAS VEGAS, NEVADA, Jan. 14, 2023 (GLOBE NEWSWIRE) — Self-Made female entrepreneur, Maricela Cortez is the Founder and CEO of Bella Glam Salon & Spa,...
January 14, 2023, 5:17 am
: drug companies plan to raise prices on vital medicines to fund r&d, but they already spend more on shareholder returns
Drug companies say they need to raise prices on cancer drugs and other treatments to fund research. But...
January 13, 2023, 4:12 pm
Neuraxis begins $33 million u.s. ipo effort
Neuraxis has filed to raise $33 million in a U.S. IPO, although the final figure may differ. The company is developing and commercializing neurostimul...
January 12, 2023, 3:12 pm
Eton pharmaceuticals announces fda acceptance of nda response for dehydrated alcohol injection
— Product previously granted orphan drug designation for methanol poisoning —— Application assigned a PDUFA date of June 27, 2023 — DEER PARK,...
January 11, 2023, 11:50 am
Gsk growing optimistic on hiv but long term challenges remain - analyst
GSK PLC (LSE:GSK, NYSE:GSK) is growing at a "robust" rate and showing increasing confidence in its HIV treatme...
January 11, 2023, 7:51 am
Innovation pharmaceuticals announces bt beamedical technologies and shina systems ltd. enter into a definitive strategic development agreement
Multiyear Development and Support Agreement Lays the Foundation for the Realization of an Advanced Software Suite to Enable Revolutionary ...
January 9, 2023, 12:30 pm
Aim immunotech broadens patent portfolio with new netherlands utility patent
AIM ImmunoTech Inc (NYSE:AIM) has announced that the Netherlands Patent Office has granted the company a utility patent covering rugged dsRNA, a doubl...
January 9, 2023, 9:25 am
Astrazeneca to acquire cincor for us$1.8bn
AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for approximately US$1.8bn in an effort to boost its ...
January 9, 2023, 7:09 am
Bioaegis leverages gelsolin’s broad therapeutic applicability by expanding into multiple inflammatory diseases
Company directs clinical effort of its breakthrough therapy to Acute Respiratory Distress Syndrome, for which there are no currently approved ...
January 6, 2023, 7:50 pm
Biontech cancer treatments deal is a coup for the government and a challenge for the nhs
BioNTech has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapi...
January 6, 2023, 12:29 pm
Abbvie and immunome partner to find new cancer treatments
Immunome and AbbVie announced a worldwide collaboration and option agreement to discover up to 10 new antibody-target pairs for treating three specifi...
January 6, 2023, 11:17 am
Baxter - steak at hamburger prices
Baxter International Inc. ( BAX , Financial) is a health care company that offers a wide range of products and services such as dialysis ...
January 6, 2023, 11:05 am
Alzheimer's drug decision day: fda to decide on biogen and eisai treatments
CNBC's Meg Tirrell joins 'Squawk Box' to discuss the big day ahead for Alzheimer's medicine....
January 6, 2023, 8:46 am
Gsk, astrazeneca: will the two uk drugs giants ride the us$74bn pharma wave or will they be left beached?
The global pharma sector is expected to see clinical trial readouts that could potentially de-risk approximately US$74bn of peak sales in 2023, accord...
January 6, 2023, 7:54 am
Uk government inks landmark deal with biontech to create cancer vaccine
The UK government is partnering with BioNTech to enrol up to 10,000 patients in clinical trials for advanced cancer ...
January 6, 2023, 3:01 am
Pfizer could sell some assets, convert others into new companies amid broader refocus
Drug maker Pfizer Inc. could part with or distance itself from some of its research programs as it rethinks its approach to early development research...
January 5, 2023, 7:29 pm
Kezar life sciences to present at the 41st annual j.p. morgan healthcare conference
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and develo...
January 4, 2023, 4:01 pm